Anti-Aging Therapeutics Volume XII

A4M American Academy

Description

Proceedings of the American Academy of Anti-Aging Medicine's (A4M) Seventeenth World Congress on Anti-Aging Medicine & Regenerative Biomedical Technologies, Spring, Summer and Winter Sessions (2009 conference year). Also includes Anti-Aging Clinical Protocols, 2010-2011.

Sujets

• Medical
• Médecine
• Clinical Medicine

Informations

• Publié par: eBookIt.com
• Date de parution: 14 juin 2011
• Nombre de lectures: 0
• EAN13: 9781934715062
• Langue: English
• Poids de l'ouvrage: 2 Mo

Extrait

Anti-Aging Therapeutics Volume XII
2009 Conference Year
Editors
Dr. Ronald Klatz
and
Dr. Robert Goldman

An official educational work published by A4M Publications
1510 West Montana Street Chicago, IL 60614 USA
TEL: [phone]; FAX: [phone]; E-MAIL: [e-mail]
WEBSITE: www.worldhealth.net
 
Visit
The World Health Network, at www. worldhealth.net , the Internet’s leading anti-aging portal;
And
The A4M’s Special Information Center, at www.a4minfo.net , the A4M’s Publishing and Media Showcase
 


IMPORTANT – PLEASE READ
The content presented in the Anti-Aging Therapeutics, volume 12 is for educational purposes only and is specifically designed for those with a health, medical, or biotechnological education or professional experience. Anti-Aging Therapeutics, volume 12 does not prevent, diagnose, treat or cure disease or illness.
While potentially therapeutic pharmaceuticals, nutraceuticals (dietary supplementation) and interventive therapies are described in the A4M's Anti-Aging Therapeutics, volume 12 , this work serves the sole purpose of functioning as an informational resource. Under no circumstances is the reader to construe endorsement by A4M of any specific companies or products. Quite to the contrary, Caveat Emptor. It is the reader's responsibility to investigate the product, the vendor, and the product information.
Dosing of nutraceuticals can be highly variable. Proper dosing is based on parameters including sex, age, and whether the patient is well or ill (and, if ill, whether it is a chronic or acute situation). Additionally, efficiency of absorption of a particular type of product and the quality of its individual ingredients are two major considerations for choosing appropriate specific agents for an individual's medical situation.
Furthermore, anyone with malignancy should consult their physician or oncologist prior to beginning, or continuing, any hormone therapy program.
Finally, please be mindful that just because a product is natural doesn't mean it's safe for everyone. A small portion of the general population may react adversely to components in nutraceuticals (especially herbal products). A complete inventory of interventions utilized by a patient should be maintained by physicians and health practitioners dispensing anti-aging medical care.
Anti-Aging Therapeutics, volume 12 is, again, designed for those with a health, medical, or biotechnological education or professional experience. It is not intended to provide medical advice, and is not to be used as a substitute for advice from a physician or health practitioner. If you are a consumer interested in any of the approaches discussed in these chapters, it is absolutely essential that you have a thorough discussion with your physician to understand all benefits and risks.
For those individuals interested in the diagnostics and/or therapies described by chapter authors of Anti-Aging Therapeutics, volume 12 , A4M urges that you consult a knowledgeable physician or health practitioner, preferably one who has been Board Certified in Anti-Aging Medicine. You may find one by utilizing the Online Physician/Practitioner Locator at the A4M's educational website, www.worldhealth.net , or you may call our international headquarters in Chicago, IL USA at [phone].
 
 
Chapter 7 Copyright © 2009 by Paul Clayton and Judith Rowbotham; licensee Molecular Diversity Preservation International, Basel, Switzerland. Article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license ( http://creativecommons.org/licenses/by/3.0/ ).
Chapter 36 Copyright © 2009 by Pramod Vora and printed with permission of the author.
Anti-Aging Therapeutics volume 12 Copyright © 2010. American Academy of Anti-Aging Medicine.
1510 West Montana Street; Chicago IL 60614 USA.
All rights reserved.
 
Published in eBook format by A4M American Academy of Anti-Aging Medicine
Converted by http://www.eBookIt.com
 
ISBN 978-1-934715-06-2 (eBook). 978-1-934715-05-5 (print & CD-ROM)
 
Electronic and/or print reproduction, storage in an electronic and/or physical retrieval system, or transmission by any means (electronic, mechanical, photocopying, microfilming, recording, or otherwise) requires the advance written consent by the publisher.
 
Chapter 1
The A4M Twelve-Point Actionable Healthcare Plan: A Blueprint for A Low Cost, High Yield Wellness Model of Healthcare
The American Academy of Anti-Aging Medicine (A4M)

 
 
Contributing Editors: Ronald M. Klatz, M.D., D.O., President & Physician Co-Founder, American Academy of Anti-Aging Medicine (A4M); Appointed member, Global Action Council on the Challenges of Gerontology, World Economic Forum; Director, World Anti-Aging Academy of Medicine Robert M. Goldman, M.D., Ph.D., D.O., FAASP, Chairman & Physician Co-Founder, American Academy of Anti-Aging Medicine (A4M); World Chairman, International Medical Commission; Chairman, World Anti-Aging Academy of Medicine; President Emeritis, National Academy of Sports Medicine Joseph C. Maroon, M.D., Professor of Neurosurgery, Heindl Scholar in Neuroscience and Vice Chairman of Neurosurgery, University of Pittsburgh Medical Center; Member of the International Editorial Board, Neurological Research and the Journal of Sports Medicine; Past President, Congress of Neurological Surgeons Nicholas A. DiNubile, M.D., Orthopaedic Consultant to the Philadelphia 76ers Basketball Team and Pennsylvania Ballet Michael Klentze, M.D., Ph.D., Secretary-General, European Society of Anti-Aging Medicine; Medical Director, Vitalife Wellness Center of Bumrungrad Hospital, Thailand
 
The American Academy of Anti-Aging Medicine (A4M; www.worldhealth.net ), the world's largest professional organization dedicated to advancing research and clinical pursuits that enhance the quality, and extend the quantity, of the human lifespan, unveils an innovative, technology-based fix to healthcare with the potential to:
• Increase the lifespan, or improve the healthspan, of all Americans by 29+ years;
• Slash healthcare costs, saving $3.7 Trillion; and
• Replace the disease-based approach to medicine with a wellness-oriented model
 
A comprehensive program to reform and advance healthcare in the United States, The A4M Twelve-Point Actionable Healthcare Plan: A Blueprint for A Low Cost, High Yield Wellness Model of Healthcare has garnered support from 35 professional medical organizations and educational institutions and was developed with invaluable input from the 24,000 physician, health practitioner, and scientist members of the American Academy of Anti-Aging Medicine (A4M; www.worldhealth.net ) who represent 110 nations worldwide.
 
The contributing editors, authors and endorsing organizations of The Twelve-Point Plan submit that the underlying philosophy of healthcare in this nation must be reformed in revolutionary new ways. In place of the disease-based approach that treats people after they exhibit signs of illness, we submit that it is time for the nation to adopt a wellness-oriented model to healthcare. Such a model stresses very early detection of illness and promotes disease prevention, yielding opportunities for the best prognoses and economical treatments. As reported by the Congressional Budget Office, up to one-third of this nation’s healthcare spending -- more than $700 billion -- does not improve Americans' health outcomes.
 
To compound the issue of healthcare reform, the United States is a driving force in a trend of unprecedented global aging. The average age of the world's population is increasing at an unprecedented rate. The number of people worldwide ages 65+ was 506 million as of midyear *2008; by 2040, that number will hit 1.3 billion. Thus, in just over 30 years, the proportion of older people will double from 7% to 14% of the total world population. In the United States, men and women ages 65+ represented 12.4% of the population in the year 2000, with that age bracket projected to swell to stand at 20% of the population by 2030. In 2007 in the United States, six major diseases among Americans ages 65+ resulted in medical and lost productivity costs of more than $196 billion. In the coming years, the cases of these six diseases, namely -- chronic lung disease, ischemic heart disease, stroke, lung cancer, pneumonia and gastrointestinal illness -- are expected to surge as the population ages, potentially sending the costs of age-related diseases skyrocketing. Steps to prepare the nation to address the social, economic, and personal ramifications of a graying society now, are urgently necessary.
 
The A4M Twelve-Point Actionable Healthcare Plan: A Blueprint for A Low Cost, High Yield Wellness Model of Healthcare provides the following practicable “here and now” solutions to reform and advance healthcare in the United States, while addressing the challenges of global aging:
 
I. Point of Care (POC) Laboratory Testing: We propose funding for development of a comprehensive, all-in-one POC laboratory testing device which will measure a set of standardized medical biomarkers of aging and thus enable the very early detection risk factors for aging-related disease.
Projected Extension in Healthspan / Lifespan: 2 ADDITIONAL YEARS PER PERSON
Projected Savings to Healthcare System: US $6.75 BILLION SAVINGS
 
 
II. Biomarkers of Aging and Health Measurement: We propose the establishment and deployment of a complete, state-of-the-science Biomarkers of Aging and Health Measurement program, to accurately assess biological age. Such data quantitatively demonstrates the benefits of various therapies for lifestyle intervention that may exert a positive effect on slowing or mitigating the degenerative process of aging. Such an Assessment Panel could be deployed across the population, thus making it possible to judiciously allocate resources wisely and efficiently,